Association between serum total antioxidant capacity and mortality in severe septic patients

Journal of Critical Care

Volumn 30, Issue 1, 2015, Pages 217.e7-217.e12

  Lorente, Leonardo ^a   Martín, María M ^b   Almeida, Teresa ^c   Abreu González, Pedro ^c   Ferreres, José ^d   Solé Violán, Jordi ^e   Labarta, Lorenzo ^f   Díaz, César ^g   Jiménez, Alejandro ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^c UNIVERSIDAD DE LA LAGUNA   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^e HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^f HOSPITAL SAN JORGE   (Spain)

^g HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

Author keywords

Mortality; Outcome; Sepsis; TAC

Indexed keywords

REACTIVE OXYGEN METABOLITE; 2,2'-AZINO-DI-(3-ETHYLBENZOTHIAZOLINE)-6-SULFONIC ACID; ANTIOXIDANT; BENZOTHIAZOLE DERIVATIVE; BIOLOGICAL MARKER; MYOGLOBIN; SULFONIC ACID DERIVATIVE;

ADULT; AGED; ANTIOXIDANT ASSAY; AREA UNDER THE CURVE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OBSERVATIONAL STUDY; OXIDATIVE STRESS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SEPSIS; SURVIVOR; BLOOD; CLINICAL TRIAL; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROGNOSIS; REGRESSION ANALYSIS; SPAIN;

ADULT; AGED; ANTIOXIDANTS; AREA UNDER CURVE; BENZOTHIAZOLES; BIOLOGICAL MARKERS; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MYOGLOBIN; OXIDATIVE STRESS; PROGNOSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; ROC CURVE; SEPSIS; SPAIN; SULFONIC ACIDS; SURVIVORS;

EID: 84920700480     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2014.09.012     Document Type: Article

References (34)

1. Vincent J.L., Sakr Y., Sprung C.L., Ranieri V.M., Reinhart K., Gerlach H., et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006, 34:344-353.
2. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310.
3. Dare A.J., Phillips A.R.J., Hickey A.J.R., Mittal A., Loveday B., Thompson N., et al. A systematic review of experimental treatments for mitochondrial dysfunction in sepsis and multiple organ dysfunction syndrome. Free Radic Biol Med 2009, 47:1517-1525.
4. Andrades M.E., Ritter C., Dal-Pizzol F. The role of free radicals in sepsis development. Front Biosci 2009, 1:277-287.
5. Ghiselli A., Serafini M., Natella F., Scaccini C. Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free Radic Biol Med 2000, 29:1106-1114.
6. Galley H.F. Oxidative stress and mitochondrial dysfunction in sepsis. Br J Anaesth 2011, 107:57-64.
7. Brealey D., Singer M. Mitochondrial dysfunction in sepsis. Curr Infect Dis Rep 2003, 5:365-371.
8. Crouser E.D. Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome. Mitochondrion 2004, 4:729-741.
9. Halliwell B., Cross C.E. Oxygen-derived species: their relation to human disease and environmental stress. Environ Health Perspect 1994, 102(Suppl. 10):5-12.
10. Young I.S., Woodside J.V. Antioxidants in health and disease. J Clin Pathol 2001, 54:176-186.
11. Dalle-Donne I., Rossi R., Colombo R., Giustarini D., Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem 2006, 52:601-623.
12. Draper H.H., Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 1990, 186:421-431.
13. Cheng C.H., Huang S.C., Chiang T.Y., Wong Y., Huang Y.C. Higher plasma pyridoxal phosphate is associated with increased antioxidant enzyme activities in critically ill surgical patients. Biomed Res Int 2013, 2013:572081.
14. Alonso de Vega J.M., Díaz J., Serrano E., Carbonell L.F. Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med 2002, 30:1782-1786.
15. Dasgupta A., Malhotra D., Levy H., Marcadis D., Blackwell W., Johnston D. Decreased total antioxidant capacity but normal lipid hydroperoxide concentrations in sera of critically ill patients. Life Sci 1997, 60:335-340.
16. MacKinnon K.L., Molnar Z., Lowe D., Watson I.D., Shearer E. Measures of total free radical activity in critically ill patients. Clin Biochem 1999, 32:263-268.
17. Tsai K., Hsu T.G., Kong C.W., Lin K., Lu F. Is the endogenous peroxyl-radical scavenging capacity of plasma protective in systemic inflammatory disorders in humans?. Free Radic Biol Med 2000, 28:926-933.
18. Karapetsa M., Pitsika M., Goutzourelas N., Stagos D., Tousia Becker A., Zakynthinos E. Oxidative status in ICU patients with septic shock. Food Chem Toxicol 2013, [pii: S0278-6915(13)00209-3, Epub ahead of print]. 10.1016/j.fct.2013.03.026.
19. Doise J.M., Aho L.S., Quenot J.P., Guilland J.C., Zeller M., Vergely C., et al. Plasma antioxidant status in septic critically ill patients: a decrease over time. Fundam Clin Pharmacol 2008, 22:203-209.
20. Chuang C.C., Shiesh S.C., Chi C.H., Tu Y.F., Hor L.I., Shieh C.C., et al. Serum total antioxidant capacity reflects severity of illness in patients with severe sepsis. Crit Care 2006, 10:R36.
21. Pascual C., Karzai W., Meier-Hellmann A., Oberhoffer M., Horn A., Bredle D., et al. Total plasma antioxidant capacity is not always decreased in sepsis. Crit Care Med 1998, 26:705-709.
22. Cowley H.C., Bacon P.J., Goode H.F., Webster N.R., Jones J.G., Menon D.K. Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors. Crit Care Med 1996, 24:1179-1183.
23. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., et al. International Sepsis Definitions Conference: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003, 29:530-538.
24. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829.
25. Vincent J.L., Moreno R., Takala J., Willatts S., De Mendonça A., Bruining H., et al. The Sepsis-related Organ Failure Assessment (SOFA) score to describe organ dysfunction/failure. Intensive Care Med 1996, 22:707-710. for the Working Group on Sepsis-related Problems of the European Society of Intensive Care Medicine.
26. Kikugawa K., Kojima T., Yamaki S., Kosugi H. Interpretation of the thiobarbituric acid reactivity of rat liver and brain homogenates in the presence of ferric ion and ethylediaminotetraacetic acid. Anal Biochem 1992, 202:249-255.
27. Buenger J., Ackermann H., Jentzsch A., Mehling A., Pfitzner I., Reiffen K.A., et al. An interlaboratory comparison of methods used to assess antioxidant potentials. Int J Cosmet Sci 2006, 28:135-146.
28. Moustafa A.H., Ali E.M., Mohamed T.M., Abdou H.I. Oxidative stress and thyroid hormones in patients with liver diseases. Eur J Intern Med 2009, 20:703-708.
29. Ogilvie A.C., Groeneveld A.B., Straub J.P., Thijs L.G. Plasma lipid peroxides and antioxidants in human septic shock. Intensive Care Med 1991, 17:40-44.
30. Wayner D.D., Burton G.W., Ingold K.U., Barclay L.R., Locke S.J. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochim Biophys Acta 1987, 924:408-419.
31. Wayner D.D., Burton G.W., Ingold K.U., Locke S. Quantitative measurement of the total, peroxyl-radical trapping antioxidant capability of human blood plasma by controlled peroxidation. FEBS Lett 1985, 187:33-37.
32. Rea C.A., Maxwell S.R., Maslin D.J., Thomason H.L., Thorpe G.H. Anticoagulant effects of antioxidant capacity. Ann Clin Biochem 1996, 33:174.
33. Lemineur T., Deby-Dupont G., Preiser J.C. Biomarkers of oxidative stress in critically ill patients: what should be measured, when and how?. Curr Opin Clin Nutr Metab Care 2006, 9:704-710.
34. Grune T., Berger M.M. Markers of oxidative stress in ICU clinical settings: present and future. Curr Opin Clin Nutr Metab Care 2007, 10:712-717.